EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
This Quarter Return
+19.85%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$1.79B
AUM Growth
+$1.79B
(+20%)
Cap. Flow
+$52.6M
Cap. Flow
% of AUM
2.94%
Top 10 Holdings %
Top 10 Hldgs %
26.42%
Holding
1,026
New
21
Increased
131
Reduced
89
Closed
43
Top Buys
| 1 |
AMRN
Amarin Corp
AMRN
|
$37.6M |
| 2 |
CELG
Celgene Corp
CELG
|
$21.2M |
| 3 |
Gilead Sciences
GILD
|
$9.48M |
| 4 |
Biogen
BIIB
|
$7.32M |
| 5 |
Intuitive Surgical
ISRG
|
$5.87M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$24.5M |
| 2 |
Meta Platforms (Facebook)
META
|
$8.82M |
| 3 |
ATVI
Activision Blizzard Inc.
ATVI
|
$7.92M |
| 4 |
VF Corp
VFC
|
$5.23M |
| 5 |
Erie Indemnity
ERIE
|
$5M |
Sector Composition
| 1 | Healthcare | 33.37% |
| 2 | Technology | 20.44% |
| 3 | Consumer Discretionary | 12.16% |
| 4 | Financials | 8.69% |
| 5 | Communication Services | 6.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Enphase Energy
ENPH
$4.93B
| $4.31M | 0.24% | 475,000 | – | – |
|
102
Exelixis
EXEL
$10.1B
| $4.16M | 0.23% | 176,200 -7,500 | -4% | -$177K |
|
103
IBM
IBM
$227B
| $4.14M | 0.23% | 29,615 | – | – |
|
104
Sunrun
RUN
$3.68B
| $4.06M | 0.23% | 284,500 -70,000 | -20% | -$999K |
|
105
JPMorgan Chase
JPM
$829B
| $4.05M | 0.23% | 40,115 +2,940 | +8% | +$297K |
|
106
FibroGen
FGEN
$47.8M
| $4M | 0.22% | 73,700 +40,300 | +121% | +$2.19M |
|
107
PNC Financial Services
PNC
$81.7B
| $3.95M | 0.22% | 32,347 +10,855 | +51% | +$1.33M |
|
108
Morgan Stanley
MS
$240B
| $3.93M | 0.22% | 93,229 +33,170 | +55% | +$1.4M |
|
109
iShares MSCI Japan ETF
EWJ
$15.3B
| $3.89M | 0.22% | 71,020 -5,300 | -7% | -$290K |
|
|
ESGR
110
DELISTED
Enstar Group
ESGR
| $3.83M | 0.21% | 22,000 -4,000 | -15% | -$696K |
|
111
Ionis Pharmaceuticals
IONS
$6.79B
| $3.83M | 0.21% | +48,000 | New | +$3.83M |
|
|
EPZM
112
DELISTED
Epizyme, Inc
EPZM
| $3.79M | 0.21% | 308,200 +40,000 | +15% | +$492K |
|
113
Nektar Therapeutics
NKTR
$568M
| $3.79M | 0.21% | 115,800 | – | – |
|
|
TERP
114
DELISTED
TerraForm Power, Inc
TERP
| $3.72M | 0.21% | 270,390 | – | – |
|
115
Electronic Arts
EA
$43B
| $3.71M | 0.21% | 36,300 +14,300 | +65% | +$1.46M |
|
|
FPRX
116
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $3.71M | 0.21% | 275,750 +95,000 | +53% | +$1.28M |
|
117
NVIDIA
NVDA
$4.24T
| $3.7M | 0.21% | 20,850 -3,660 | -15% | -$649K |
|
|
SGEN
118
DELISTED
Seagen Inc. Common Stock
SGEN
| $3.64M | 0.2% | 50,750 | – | – |
|
|
KDNY
119
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $3.64M | 0.2% | 919,349 +494,349 | +116% | +$1.96M |
|
120
Lincoln National
LNC
$8.14B
| $3.64M | 0.2% | 62,170 +570 | +0.9% | +$33.4K |
|
|
JNCE
121
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $3.52M | 0.2% | 568,687 +258,587 | +83% | +$1.6M |
|
122
Comcast
CMCSA
$125B
| $3.49M | 0.2% | 87,081 +6,365 | +8% | +$255K |
|
|
ONC
123
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $3.49M | 0.2% | 27,600 | – | – |
|
124
Manulife Financial
MFC
$52.2B
| $3.47M | 0.19% | 204,300 -4,700 | -2% | -$79.8K |
|
125
Salesforce
CRM
$245B
| $3.36M | 0.19% | 21,640 +4,560 | +27% | +$708K |
|